Diamyd Medical provides an update following the receipt of final meeting minutes from a positive Type C meeting with the U.S. Food and Drug Administration (FDA) held in December 2024. The meeting ...
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and ...
The new approach is designed to create a connection between the left and right atrial chambers of the heart in a single ...
Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...
The U.S. food supply is generally considered safe, but tens of millions of people get sick from foodborne illnesses each year ...
Independence Blue Cross has instituted an 18-month benefit exclusion on certain drugs that receive accelerated approval from ...
The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.
The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with ...
The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.
The Food and Drug Administration have seen a number of food items pulled from the shelves since the start of 2025, with the ...
The Food and Drug Administration (FDA) recently issued a Notice announcing the availability of an updated final guidance for the industry ...